Abstract

DNA methylation is a repressive epigenetic modification that is essential for development, exemplified by the embryonic and perinatal lethality observed in mice lacking de novo DNA methyltransferases (DNMTs). Here we characterise the role for DNMT3A, 3B and 3L in gene regulation and development of the mouse placenta. We find that each DNMT establishes unique aspects of the placental methylome through targeting to distinct chromatin features. Loss of Dnmt3b results in de-repression of germline genes in trophoblast lineages and impaired formation of the maternal-foetal interface in the placental labyrinth. Using Sox2-Cre to delete Dnmt3b in the embryo, leaving expression intact in placental cells, the placental phenotype was rescued and, consequently, the embryonic lethality, as Dnmt3b null embryos could now survive to birth. We conclude that de novo DNA methylation by DNMT3B during embryogenesis is principally required to regulate placental development and function, which in turn is critical for embryo survival.

DNA methylation is a repressive modification that is essential for development. Here the authors reveal a critical role for DNA methylation in placental development during pregnancy. Failure to properly establish placental DNA methylation patterns compromises not only placental function, but embryo survival.

Details

Title
Mechanisms and function of de novo DNA methylation in placental development reveals an essential role for DNMT3B
Author
Andrews, Simon 1   VIAFID ORCID Logo  ; Krueger, Christel 2   VIAFID ORCID Logo  ; Mellado-Lopez, Maravillas 3 ; Hemberger, Myriam 4   VIAFID ORCID Logo  ; Dean, Wendy 5   VIAFID ORCID Logo  ; Perez-Garcia, Vicente 3 ; Hanna, Courtney W. 6   VIAFID ORCID Logo 

 Babraham Institute, Bioinformatics Programme, Cambridge, UK (GRID:grid.418195.0) (ISNI:0000 0001 0694 2777) 
 Babraham Institute, Bioinformatics Programme, Cambridge, UK (GRID:grid.418195.0) (ISNI:0000 0001 0694 2777); Babraham Institute, Epigenetics Programme, Cambridge, UK (GRID:grid.418195.0) (ISNI:0000 0001 0694 2777); Altos Labs Cambridge Institute, Bioinformatics Innovation Hub, Cambridge, UK (GRID:grid.418195.0) 
 Centro de Investigación Príncipe Felipe, Valencia, Spain (GRID:grid.418274.c) (ISNI:0000 0004 0399 600X) 
 University of Calgary, Department of Biochemistry and Molecular Biology, Cumming School of Medicine, Calgary, Canada (GRID:grid.22072.35) (ISNI:0000 0004 1936 7697); University of Calgary, Department of Medical Genetics, Cumming School of Medicine, Calgary, Canada (GRID:grid.22072.35) (ISNI:0000 0004 1936 7697); University of Calgary, Alberta Children’s Hospital Research Institute, Calgary, Canada (GRID:grid.22072.35) (ISNI:0000 0004 1936 7697) 
 University of Calgary, Alberta Children’s Hospital Research Institute, Calgary, Canada (GRID:grid.22072.35) (ISNI:0000 0004 1936 7697); University of Calgary, Department of Cell Biology and Anatomy, Calgary, Canada (GRID:grid.22072.35) (ISNI:0000 0004 1936 7697) 
 Babraham Institute, Epigenetics Programme, Cambridge, UK (GRID:grid.418195.0) (ISNI:0000 0001 0694 2777); University of Cambridge, Department of Physiology, Development and Neuroscience, Cambridge, UK (GRID:grid.5335.0) (ISNI:0000000121885934); University of Cambridge, Centre for Trophoblast Research, Cambridge, UK (GRID:grid.5335.0) (ISNI:0000000121885934) 
Pages
371
Publication year
2023
Publication date
2023
Publisher
Nature Publishing Group
e-ISSN
20411723
Source type
Scholarly Journal
Language of publication
English
ProQuest document ID
2768590201
Copyright
© The Author(s) 2023. This work is published under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.